作者
Ashley Taepakdee,Skylar McDonald,Zachary A. Molander,Geoffrey Philip Colby,V.G.J. Rodgers,Gerhard A. Holzapfel,Chung‐Hao Lee
摘要
Bioresorbable flow diverters (BRFDs) represent an emerging treatment for intracranial aneurysms (IAs) that avoids complications associated with permanent flow diverters, as BRFDs—due to their temporary nature—restore native blood flow following degrading. BRFDs’ therapeutic efficacy depends on material degradation, hemodynamics, thrombosis, and endothelialization, but there is currently a lack of computational models enabling a holistic evaluation of the interplay between these processes—a critical need, however. This review summarizes different modeling approaches for the degradation of bioresorbable metals, including continuum damage mechanics (CDM), mechanochemical phase-field, and reaction-diffusion models. It evaluates the suitability of each structure for integration with computational fluid dynamics (CFD) for guiding flow-diverting devices in IA treatment. CDM approaches focus on the degradation of mechanical integrity and do not directly consider electrochemical transport, whereas mechanochemical models account for mechanical, chemical, and electrochemical processes, providing detailed information on localized corrosion, albeit at a higher computational cost. Reaction-diffusion models are the most practical option for coupling with CFD, offering a balance between accuracy in describing underlying mechanisms and computational feasibility. Critical gaps in BRFD models include the limited use of metals such as iron (Fe), zinc (Zn), and/or molybdenum (Mo), as well as specific aspects of blood chemistry. Additionally, no standardized validation protocol currently exists for computational models of BRFDs. Thus, a multiscale, multi-physics framework—integrating material degradation, hemodynamics, and biological responses (e.g., thrombosis/endothelialization) and carefully validated against in vitro and/or in vivo data—will be essential for advancing the design and assessing the therapeutic efficacy of BRFDs.